(Q34680250)

English

Elliptinium: phase II study in advanced measurable breast cancer

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Elliptinium: phase II study in advanced measurable breast cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

author name string

Treat J

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Greenspan A

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Rahman A

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

McCabe MS

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Byrne PJ

5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

publication date

1 July 1989

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Investigational New Drugs

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

2-3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

231-234

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Drug-induced antibodies during 2-N-methyl-9-hydroxyellipticinium acetate (NSC-264137) treatment: schedule dependency and relationship to hemolysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2793378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study of elliptinium (2-N-methyl-9-hydroxyellipticinium)

1 reference

https://pubmed.ncbi.nlm.nih.gov/2793378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alkaloids of Ochrosia maculata Jacq. (Ochrosia borbonica Gmel.). Isolation of the alkaloids and study of the antitumor properties of 9-methoxyellipticine

1 reference

https://pubmed.ncbi.nlm.nih.gov/2793378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hydroxy-9-methyl-2-ellipticinium for osseous metastases from breast cancer: a 5-year experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/2793378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00170864

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34680250&oldid=2196943864"